These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Usefulness of molecular analysis in the differential diagnosis of congenital 21-hidroxylase deficiency detected in neonatal screening]. Soriano Guillén L; Velázquez De Cuellar Paracchi M; Ezquieta B Med Clin (Barc); 2011 Mar; 136(7):313-4. PubMed ID: 19766262 [No Abstract] [Full Text] [Related]
7. Heterozygosis for CYP21A2 mutation considered as 21-hydroxylase deficiency in neonatal screening. Soardi FC; Lemos-Marini SH; Coeli FB; Maturana VG; Silva MD; Bernardi RD; Justo GZ; de-Mello MP Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1388-92. PubMed ID: 19169499 [TBL] [Abstract][Full Text] [Related]
8. Procedure for neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology Horm Res; 2001; 55(4):201-5. PubMed ID: 11598375 [TBL] [Abstract][Full Text] [Related]
10. The value of time in assessing the effectiveness of newborn screening for congenital adrenal hyperplasia. Tarini BA JAMA Pediatr; 2014 Jun; 168(6):515-6. PubMed ID: 24733500 [No Abstract] [Full Text] [Related]
11. Does newborn screening have 100% sensitivity to detect salt wasting congenital adrenal hyperplasia?-Reply. Gidlöf S; Nordenström A JAMA Pediatr; 2014 Oct; 168(10):971. PubMed ID: 25285872 [No Abstract] [Full Text] [Related]
12. Does newborn screening have 100% sensitivity to detect salt-wasting congenital adrenal hyperplasia?: A word of caution. Grosse SD; Sarafoglou K JAMA Pediatr; 2014 Oct; 168(10):970-1. PubMed ID: 25285869 [No Abstract] [Full Text] [Related]
14. CYP21A2 gene mutation in South Indian children with congenital adrenal hyperplasia. Ganesh R; Suresh N; Janakiraman L; Ravikumar K Indian Pediatr; 2015 Aug; 52(8):710-1. PubMed ID: 26388637 [No Abstract] [Full Text] [Related]